Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Mar 2026 for Krystal Biotech, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kathryn Romano: trading record in brief
All filings by Kathryn Romano on record concern Krystal Biotech, Inc., in the capacity of finance chief. Between 26 February 2022 and 27 February 2026, the trades on record add up to 10 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 3 March 2026 came the latest disclosure, an option exercise in Krystal Biotech, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kathryn Romano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
7,500 shares0Common StockSEC:0001801385-26-000002:0
12,500 shares@ US$63.5549.3% of flowCommon StockSEC:0001711279-26-000011:0
2,268 shares@ US$176.3955.1% of flowCommon StockSEC:0001801385-25-000002:0
523 shares@ US$63.554.4% of flowCommon StockSEC:0001801385-24-000009:0
648 shares@ US$63.555.5% of flowCommon StockSEC:0001801385-24-000011:0
5,000 shares@ US$52.2635.0% of flowCommon StockSEC:0001801385-24-000007:0
2,500 shares@ US$52.2612.4% of flowCommon StockSEC:0001801385-24-000002:0
12,500 shares@ US$52.2662.7% of flowCommon StockSEC:0001801385-23-000004:0
2,144 shares@ US$78.4616.4% of flowCommon StockSEC:0001801385-23-000002:0
1,472 shares@ US$62.500.0011% mcap100.0% of flowCommon StockSEC:0001801385-22-000005:0
10 of 10 declarations
